Gold nanoparticles can be used as delivery vehicles for platinum anticancer drugs, improving targeting and uptake into cells, according to research published in this month’s edition of the international journal Inorganic Chemistry. [ + ]

Brisbane-based company Bilexys, originating from The University of Queensland (UQ), has won the Pre-Revenue Track award in the US$200,000 Imagine H20 2011 Prize - the world’s premier competition for water start-up companies. [ + ]

The Raising the Bar Bill that reforms Australia’s intellectual property laws has passed both houses of parliament and will soon be signed into law. [ + ]

Melbourne's HealthLinx (ASX:HTX) has taken another step towards gaining regulatory approval to sell OvPlex in South Korea, by laying the groundwork for a trial. [ + ]

Biota (ASX:BTA) will expand its facilities in Melbourne to allow it to fulfil a $220m contract for the advanced development of a influenza antiviral in the US. [ + ]

Melbourne's Patrys Limited (ASX:PAB) has published the results of a safety and tolerability trial of anti-cancer antibody PAT-SM6. [ + ]

AusBiotech’s 2012 CEO Biotechnology Industry Position Survey will be launched by AusBiotech’s CEO, Dr Anna Lavelle, at the member-only briefings in April. [ + ]

Pharmaxis’ cystic fibrosis treatment Bronchitol is slated to be listed on the Pharmaceutical Benefits Scheme for reimbursement. [ + ]

Biotechnology and pharmaceutical industry veteran and GBS Ventures partner, Dr Andrew Baker, died on Sunday March 18 from cancer. [ + ]

A group of buyers including Elliott Management have purchased $23m worth of CDIs and shares in ASX-listed US medical device company REVA Medical (ASX:RVA). [ + ]

QRxPharma (ASX:QRX) has closed a deal to license its dual-opioid pain product, MoxDuo IR, to pharmaceutical company Actavis. [ + ]

Professor Emily Hilder, from the University of Tasmania, has won the prestigious LCGC 2012 Emerging Leader in Chromatography Award. This is the first time the award has been presented to an Australian researcher and the first time to a female researcher. [ + ]

Dual-listed biotech Bioniche (ASX:BNC) has negotiated to receive a $19m, non-dilutive finance facility from the USA's Capital Royalty. [ + ]

The $10 million Asia-Pacific Centre for Neuromodulation will focus on deep brain stimulation and seek to become an international hub for brain research. [ + ]

Congratulations to Carla Mathews from Austin Health, who has won an iPad after completing the recent What’s New in LAB Technology survey. [ + ]